First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform MILWAUKEE and CAMBRIDGE, Mass.

Sprint has announced that its accelerator will no longer focus specifically on digital health technologies, and instead will accept startups that are focusing on any mobile technology. The Sprint ...